Tenaya Therapeutics, Inc. (NASDAQ:TNYA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eli Casdin Other companies: Standard BioTools Inc. (Director · Since at least Apr 4, 2022); GeneDx Holdings Corp. (Board Member · Since at least Sep 1, 2020); 2Seventy Bio Inc (Director · Mar 20, 2024 – May 13, 2025 · Past); EQRx Inc (Director · Dec 17, 2021 – Sep 30, 2022 · Past); Absci Corporation (Director · Jul 21, 2021 – Jun 8, 2022 · Past); Century Therapeutics, Inc. (Director · Jun 17, 2021 – Jun 9, 2022 · Past); CM Life Sciences III Inc. (Officer (CEO), Director · Apr 6, 2021 – Aug 1, 2021 · Past); EXACT Sciences Corporation (Director · Oct 26, 2017 – Jul 23, 2020 · Past) | Director · Jul 29, 2021 – Nov 17, 2022 · Past |
| Leone Patterson Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Apr 3, 2025); Zymeworks Inc. (EVP, Chief Bus & Fin Officer · Since at least Sep 1, 2024); Nkarta, Inc. (Member of Board of Directors · Since at least Jul 9, 2020); Climb Bio, Inc. (Director · Aug 9, 2021 – May 19, 2022 · Past); Adverum Biotechnologies Inc (President and CFO · Jun 15, 2016 – Feb 16, 2021 · Past); Paratek Pharmaceuticals Inc (Vice President, CFO · Jun 25, 2012 – Oct 30, 2014 · Past) | Chief Fin. and Bus. Officer · Jul 29, 2021 – Feb 23, 2024 · Past |
| Karah Parschauer Other companies: Evolus, Inc. Common Stock (Director · Since at least Jul 15, 2019); Ultragenyx Pharmaceutical Inc. (EVP and Chief Legal Officer · Since at least Jun 20, 2016); Anebulo Pharmaceuticals, Inc. (Director · May 6, 2021 – Apr 21, 2022 · Past); Arcturus Therapeutics Holdings Inc. (Director · Jun 19, 2019 – Jun 18, 2021 · Past) | Board Member · Since at least Dec 22, 2021 |
| Catherine Stehman-Breen Other companies: Dyne Therapeutics, Inc. (Board Member · Since at least Jul 31, 2020); Generation Bio Co (Director · Since at least Jun 11, 2020); Sarepta Therapeutics, Inc. (SVP, Chief Medical Officer · Apr 3, 2017 – Apr 3, 2017 · Past) | Board Member · Since at least Jul 29, 2021 |
| David V Goeddel Other companies: Nurix Therapeutics, Inc. (Director · Jul 28, 2020 – Jul 28, 2020 · Past); RAPT Therapeutics Inc (Director · Oct 30, 2019 – Nov 4, 2019 · Past); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 5, 2024 · Past) | Director · Since at least Jul 29, 2021 |
| June Lee Other companies: Eledon Pharmaceuticals, Inc. (Director · Since at least Dec 8, 2020); CinCor Pharma Inc (Director · Jan 6, 2022 – Feb 24, 2023 · Past); MyoKardia Inc (EVP, Chief Development Officer · Jan 31, 2017 – Oct 29, 2019 · Past) | Board Member · Since at least Nov 19, 2021 |
| R. Sanders Williams Other companies: Amgen Inc. (Director · Oct 17, 2014 – May 19, 2023 · Past); Labcorp Holdings Inc. (Director · May 16, 2007 – Feb 6, 2024 · Past); Bristol-Myers Squibb Company (Director · Sep 11, 2006 – Feb 1, 2013 · Past) | Chair of the Board · Since at least Jul 29, 2021 |
| Amy Burroughs Other companies: Terns Pharmaceuticals, Inc. (Chief Executive Officer, Director · Since at least Feb 7, 2024); DiaMedica Therapeutics Inc. (Director · Jul 15, 2021 – Jan 3, 2023 · Past) | Board Member · Since at least Dec 5, 2022 |
| Eric Hyllengren Other companies: Zura Bio Limited (Chief Financial Officer · Since at least Jul 1, 2025); Atara Biotherapeutics, Inc. (EVP, CFO and COO · Apr 1, 2023 – Mar 3, 2025 · Past) | Chief Financial Officer · Since at least Jun 29, 2026 |
| Faraz Ali Other companies: Regenxbio Inc. (Chief Business Officer · Feb 29, 2016 – Jan 4, 2017 · Past) | Chief Executive Officer · Since at least Jul 29, 2021 |
| Jeffrey T. Walsh Other companies: Bluebird bio Inc (Chief Strategy Officer · Mar 11, 2019 – Aug 20, 2019 · Past) | Board Member · Since at least Jul 29, 2021 |
| Jin-Long Chen Other companies: NGM Biopharmaceuticals Inc (Chief Scientific Officer, Director · Apr 3, 2019 – Mar 2, 2023 · Past) | Director · Jul 29, 2021 – Jun 9, 2023 · Past |
| Timothy Hoey Other companies: OncoMed Pharmaceuticals Inc (SVP, Cancer Biology & Co-CSO · Jul 17, 2013 – Apr 23, 2017 · Past) | Chief Scientific Officer · Jul 29, 2021 – Mar 5, 2024 · Past |
| Chihiro Saito | SVP, Accounting and Fin. Ops. · Aug 14, 2024 – Nov 18, 2024 · Past |
| Deepak Srivastava | Board Member · Since at least Jul 29, 2021 |
| Hiro Higa | Senior Vice President · Until Jun 29, 2026 · Past |
| Jay Vora | Senior Vice President, Portfolio and Program Management · Since at least Nov 4, 2026 |
| JeenJoo Kang | Director · Jul 29, 2021 – Aug 3, 2021 · Past |
| Jennifer Drimmer | General Counsel · Since at least Nov 4, 2026 |
| Joanna Auch | Senior Vice President, People and Culture · Since at least Nov 4, 2026 |
| Kathy Ivey | Senior Vice President, Research · Since at least Mar 9, 2026 |
| Kee-Hong Kim | Chief Technology Officer · Since at least Nov 4, 2026 |
| Tomohiro Higa | SVP, Finance · Since at least Feb 6, 2025 |
| Whittemore Tingley | Chief Medical Officer · Since at least Jul 29, 2021 |
| Whit Tingley | Chief Medical Officer · Since at least Jun 3, 2026 |